1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Opioids Drug Consumption 2016-2026 2.1.2 Opioids Drug Consumption CAGR by Region 2.2 Opioids Drug Segment by Type 2.2.1 Oxycodone 2.2.2 Hydromorphone 2.2.3 Codeine 2.2.4 Fentanyl 2.3 Opioids Drug Sales by Type 2.3.1 Global Opioids Drug Sales Market Share by Type (2016-2021) 2.3.2 Global Opioids Drug Revenue and Market Share by Type (2016-2021) 2.3.3 Global Opioids Drug Sale Price by Type (2016-2021) 2.4 Opioids Drug Segment by Application 2.4.1 Pain Relief 2.4.2 Anesthesia 2.4.3 Others 2.5 Opioids Drug Sales by Application 2.5.1 Global Opioids Drug Sale Market Share by Application (2016-2021) 2.5.2 Global Opioids Drug Revenue and Market Share by Application (2016-2021) 2.5.3 Global Opioids Drug Sale Price by Application (2016-2021) 3 Global Opioids Drug by Company 3.1 Global Opioids Drug Sales Market Share by Company 3.1.1 Global Opioids Drug Sales by Company (2019-2021) 3.1.2 Global Opioids Drug Sales Market Share by Company (2019-2021) 3.2 Global Opioids Drug Revenue Market Share by Company 3.2.1 Global Opioids Drug Revenue by Company (2019-2021) 3.2.2 Global Opioids Drug Revenue Market Share by Company (2019-2021) 3.3 Global Opioids Drug Sale Price by Company 3.4 Global Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Opioids Drug Product Location Distribution 3.4.2 Players Opioids Drug Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Opioids Drug by Region 4.1 Global Opioids Drug by Region 4.1.1 Global Opioids Drug Sales by Region 4.1.2 Global Opioids Drug Revenue by Region 4.2 Americas Opioids Drug Sales Growth 4.3 APAC Opioids Drug Sales Growth 4.4 Europe Opioids Drug Sales Growth 4.5 Middle East & Africa Opioids Drug Sales Growth 5 Americas 5.1 Americas Opioids Drug Sales by Country 5.1.1 Americas Opioids Drug Sales by Country (2016-2021) 5.1.2 Americas Opioids Drug Revenue by Country (2016-2021) 5.2 Americas Opioids Drug Sales by Type 5.3 Americas Opioids Drug Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Opioids Drug Sales by Region 6.1.1 APAC Opioids Drug Sales by Region (2016-2021) 6.1.2 APAC Opioids Drug Revenue by Region (2016-2021) 6.2 APAC Opioids Drug Sales by Type 6.3 APAC Opioids Drug Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Opioids Drug by Country 7.1.1 Europe Opioids Drug Sales by Country (2016-2021) 7.1.2 Europe Opioids Drug Revenue by Country (2016-2021) 7.2 Europe Opioids Drug Sales by Type 7.3 Europe Opioids Drug Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Opioids Drug by Country 8.1.1 Middle East & Africa Opioids Drug Sales by Country (2016-2021) 8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2016-2021) 8.2 Middle East & Africa Opioids Drug Sales by Type 8.3 Middle East & Africa Opioids Drug Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Opioids Drug Distributors 10.3 Opioids Drug Customer 11 Global Opioids Drug Market Forecast 11.1 Global Opioids Drug Forecast by Region 11.1.1 Global Opioids Drug Forecast by Regions (2021-2026) 11.2.2 Global Opioids Drug Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Opioids Drug Forecast by Type 11.7 Global Opioids Drug Forecast by Application 12 Key Players Analysis 12.1 Teva 12.1.1 Teva Company Information 12.1.2 Teva Opioids Drug Product Offered 12.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Teva Main Business Overview 12.1.5 Teva Latest Developments 12.2 Purdue Pharma 12.2.1 Purdue Pharma Company Information 12.2.2 Purdue Pharma Opioids Drug Product Offered 12.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Purdue Pharma Main Business Overview 12.2.5 Purdue Pharma Latest Developments 12.3 Mallinckrodt 12.3.1 Mallinckrodt Company Information 12.3.2 Mallinckrodt Opioids Drug Product Offered 12.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Mallinckrodt Main Business Overview 12.3.5 Mallinckrodt Latest Developments 12.4 Amneal Pharma 12.4.1 Amneal Pharma Company Information 12.4.2 Amneal Pharma Opioids Drug Product Offered 12.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Amneal Pharma Main Business Overview 12.4.5 Amneal Pharma Latest Developments 12.5 Collegium 12.5.1 Collegium Company Information 12.5.2 Collegium Opioids Drug Product Offered 12.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Collegium Main Business Overview 12.5.5 Collegium Latest Developments 12.6 J&J 12.6.1 J&J Company Information 12.6.2 J&J Opioids Drug Product Offered 12.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 J&J Main Business Overview 12.6.5 J&J Latest Developments 12.7 Endo 12.7.1 Endo Company Information 12.7.2 Endo Opioids Drug Product Offered 12.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 Endo Main Business Overview 12.7.5 Endo Latest Developments 12.8 Pfizer 12.8.1 Pfizer Company Information 12.8.2 Pfizer Opioids Drug Product Offered 12.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 Pfizer Main Business Overview 12.8.5 Pfizer Latest Developments 12.9 INSYS 12.9.1 INSYS Company Information 12.9.2 INSYS Opioids Drug Product Offered 12.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.9.4 INSYS Main Business Overview 12.9.5 INSYS Latest Developments 12.10 Mylan 12.10.1 Mylan Company Information 12.10.2 Mylan Opioids Drug Product Offered 12.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.10.4 Mylan Main Business Overview 12.10.5 Mylan Latest Developments 12.11 Hikma 12.11.1 Hikma Company Information 12.11.2 Hikma Opioids Drug Product Offered 12.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.11.4 Hikma Main Business Overview 12.11.5 Hikma Latest Developments 12.12 Egalet 12.12.1 Egalet Company Information 12.12.2 Egalet Opioids Drug Product Offered 12.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2019-2021) 12.12.4 Egalet Main Business Overview 12.12.5 Egalet Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Opioids Drug Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Oxycodone Table 3. Major Players of Hydromorphone Table 4. Major Players of Codeine Table 5. Major Players of Fentanyl Table 6. Global Opioids Drug Sales by Type (2016-2021) & (M Units) Table 7. Global Opioids Drug Sales Market Share by Type (2016-2021) Table 8. Global Opioids Drug Revenue by Type (2016-2021) & ($ million) Table 9. Global Opioids Drug Revenue Market Share by Type (2016-2021) Table 10. Global Opioids Drug Sale Price by Type (2016-2021) Table 11. Global Opioids Drug Sales by Application (2016-2021) & (M Units) Table 12. Global Opioids Drug Sales Market Share by Application (2016-2021) Table 13. Global Opioids Drug Value by Application (2016-2021) Table 14. Global Opioids Drug Revenue Market Share by Application (2016-2021) Table 15. Global Opioids Drug Sale Price by Application (2016-2021) Table 16. Global Opioids Drug Sales by Company (2019-2021) & (M Units) Table 17. Global Opioids Drug Sales Market Share by Company (2019-2021) Table 18. Global Opioids Drug Revenue by Company (2019-2021) ($ Millions) Table 19. Global Opioids Drug Revenue Market Share by Company (2019-2021) Table 20. Global Opioids Drug Sale Price by Company (2019-2021) Table 21. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area Table 22. Players Opioids Drug Products Offered Table 23. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Opioids Drug Sales by Region (2016-2021) (M Units) Table 27. Global Opioids Drug Sales Market Share by Region (2016-2021) Table 28. Global Opioids Drug Revenue by Region (2016-2021) & ($ Millions) Table 29. Global Opioids Drug Revenue Market Share by Region (2016-2021) Table 30. Americas Opioids Drug Sales by Country (2016-2021) & (M Units) Table 31. Americas Opioids Drug Sales Market Share by Country (2016-2021) Table 32. Americas Opioids Drug Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas Opioids Drug Revenue Market Share by Country (2016-2021) Table 34. Americas Opioids Drug Sales by Type (2016-2021) & (M Units) Table 35. Americas Opioids Drug Sales Market Share by Type (2016-2021) Table 36. Americas Opioids Drug Sales by Application (2016-2021) & (M Units) Table 37. Americas Opioids Drug Sales Market Share by Application (2016-2021) Table 38. APAC Opioids Drug Sales by Region (2016-2021) & (M Units) Table 39. APAC Opioids Drug Sales Market Share by Region (2016-2021) Table 40. APAC Opioids Drug Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC Opioids Drug Revenue Market Share by Region (2016-2021) Table 42. APAC Opioids Drug Sales by Type (2016-2021) & (M Units) Table 43. APAC Opioids Drug Sales Market Share by Type (2016-2021) Table 44. APAC Opioids Drug Sales by Application (2016-2021) & (M Units) Table 45. APAC Opioids Drug Sales Market Share by Application (2016-2021) Table 46. Europe Opioids Drug Sales by Country (2016-2021) & (M Units) Table 47. Europe Opioids Drug Sales Market Share by Country (2016-2021) Table 48. Europe Opioids Drug Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe Opioids Drug Revenue Market Share by Country (2016-2021) Table 50. Europe Opioids Drug Sales by Type (2016-2021) & (M Units) Table 51. Europe Opioids Drug Sales Market Share by Type (2016-2021) Table 52. Europe Opioids Drug Sales by Application (2016-2021) & (M Units) Table 53. Europe Opioids Drug Sales Market Share by Application (2016-2021) Table 54. Middle East & Africa Opioids Drug Sales by Country (2016-2021) & (M Units) Table 55. Middle East & Africa Opioids Drug Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa Opioids Drug Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa Opioids Drug Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa Opioids Drug Sales by Type (2016-2021) & (M Units) Table 59. Middle East & Africa Opioids Drug Sales Market Share by Type (2016-2021) Table 60. Middle East & Africa Opioids Drug Sales by Application (2016-2021) & (M Units) Table 61. Middle East & Africa Opioids Drug Sales Market Share by Application (2016-2021) Table 62. Key and Potential Regions of Opioids Drug Table 63. Key Application and Potential Industries of Opioids Drug Table 64. Key Challenges of Opioids Drug Table 65. Key Trends of Opioids Drug Table 66. Opioids Drug Distributors List Table 67. Opioids Drug Customer List Table 68. Global Opioids Drug Sales Forecast by Region (2021-2026) & (M Units) Table 69. Global Opioids Drug Consumption Market Forecast by Region Table 70. Global Opioids Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 71. Global Opioids Drug Revenue Market Share Forecast by Region (2021-2026) Table 72. Americas Opioids Drug Sales Forecast by Country (2021-2026) & (M Units) Table 73. Americas Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 74. APAC Opioids Drug Sales Forecast by Region (2021-2026) & (M Units) Table 75. APAC Opioids Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 76. Europe Opioids Drug Sales Forecast by Country (2021-2026) & (M Units) Table 77. Europe Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Middle East & Africa Opioids Drug Sales Forecast by Country (2021-2026) & (M Units) Table 79. Middle East & Africa Opioids Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Global Opioids Drug Sales Forecast by Type (2021-2026) & (M Units) Table 81. Global Opioids Drug Sales Market Share Forecast by Type (2021-2026) Table 82. Global Opioids Drug Revenue Forecast by Type (2021-2026) & ($ Millions) Table 83. Global Opioids Drug Revenue Market Share Forecast by Type (2021-2026) Table 84. Global Opioids Drug Sales Forecast by Application (2021-2026) & (M Units) Table 85. Global Opioids Drug Sales Market Share Forecast by Application (2021-2026) Table 86. Global Opioids Drug Revenue Forecast by Application (2021-2026) & ($ Millions) Table 87. Global Opioids Drug Revenue Market Share Forecast by Application (2021-2026) Table 88. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 89. Teva Opioids Drug Product Offered Table 90. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 91. Teva Main Business Table 92. Teva Latest Developments Table 93. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 94. Purdue Pharma Opioids Drug Product Offered Table 95. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 96. Purdue Pharma Main Business Table 97. Purdue Pharma Latest Developments Table 98. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 99. Mallinckrodt Opioids Drug Product Offered Table 100. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 101. Mallinckrodt Main Business Table 102. Mallinckrodt Latest Developments Table 103. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 104. Amneal Pharma Opioids Drug Product Offered Table 105. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 106. Amneal Pharma Main Business Table 107. Amneal Pharma Latest Developments Table 108. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 109. Collegium Opioids Drug Product Offered Table 110. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 111. Collegium Main Business Table 112. Collegium Latest Developments Table 113. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 114. J&J Opioids Drug Product Offered Table 115. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 116. J&J Main Business Table 117. J&J Latest Developments Table 118. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 119. Endo Opioids Drug Product Offered Table 120. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 121. Endo Main Business Table 122. Endo Latest Developments Table 123. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 124. Pfizer Opioids Drug Product Offered Table 125. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 126. Pfizer Main Business Table 127. Pfizer Latest Developments Table 128. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 129. INSYS Opioids Drug Product Offered Table 130. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 131. INSYS Main Business Table 132. INSYS Latest Developments Table 133. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 134. Mylan Opioids Drug Product Offered Table 135. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 136. Mylan Main Business Table 137. Mylan Latest Developments Table 138. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 139. Hikma Opioids Drug Product Offered Table 140. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 141. Hikma Main Business Table 142. Hikma Latest Developments Table 143. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors Table 144. Egalet Opioids Drug Product Offered Table 145. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 146. Egalet Main Business Table 147. Egalet Latest Developments List of Figures Figure 1. Picture of Opioids Drug Figure 2. Opioids Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Opioids Drug Sales Growth Rate 2016-2026 (M Units) Figure 7. Global Opioids Drug Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Opioids Drug Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Oxycodone Figure 10. Product Picture of Hydromorphone Figure 11. Product Picture of Codeine Figure 12. Product Picture of Fentanyl Figure 13. Global Opioids Drug Sales Market Share by Type in 2020 Figure 14. Global Opioids Drug Revenue Market Share by Type (2016-2021) Figure 15. Opioids Drug Consumed in Pain Relief Figure 16. Global Opioids Drug Market: Pain Relief (2016-2021) & (M Units) Figure 17. Opioids Drug Consumed in Anesthesia Figure 18. Global Opioids Drug Market: Anesthesia (2016-2021) & (M Units) Figure 19. Opioids Drug Consumed in Others Figure 20. Global Opioids Drug Market: Others (2016-2021) & (M Units) Figure 21. Global Opioids Drug Sales Market Share by Application (2016-2021) Figure 22. Global Opioids Drug Revenue Market Share by Application in 2020 Figure 23. Opioids Drug Revenue Market by Company in 2020 ($ Million) Figure 24. Global Opioids Drug Revenue Market Share by Company in 2020 Figure 25. Global Opioids Drug Sales Market Share by Regions (2016-2021) Figure 26. Global Opioids Drug Revenue Market Share by Region in 2020 Figure 27. Americas Opioids Drug Sales 2016-2021 (M Units) Figure 28. Americas Opioids Drug Revenue 2016-2021 ($ Millions) Figure 29. APAC Opioids Drug Sales 2016-2021 (M Units) Figure 30. APAC Opioids Drug Revenue 2016-2021 ($ Millions) Figure 31. Europe Opioids Drug Sales 2016-2021 (M Units) Figure 32. Europe Opioids Drug Revenue 2016-2021 ($ Millions) Figure 33. Middle East & Africa Opioids Drug Sales 2016-2021 (M Units) Figure 34. Middle East & Africa Opioids Drug Revenue 2016-2021 ($ Millions) Figure 35. Americas Opioids Drug Sales Market Share by Country in 2020 Figure 36. Americas Opioids Drug Revenue Market Share by Country in 2020 Figure 37. Americas Opioids Drug Sales Market Share by Type in 2020 Figure 38. Americas Opioids Drug Sales Market Share by Application in 2020 Figure 39. United States Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 40. Canada Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 41. Mexico Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 42. Brazil Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 43. APAC Opioids Drug Sales Market Share by Region in 2020 Figure 44. APAC Opioids Drug Revenue Market Share by Regions in 2020 Figure 45. APAC Opioids Drug Sales Market Share by Type in 2020 Figure 46. APAC Opioids Drug Sales Market Share by Application in 2020 Figure 47. China Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 48. Japan Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 49. Korea Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 50. Southeast Asia Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 51. India Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 52. Australia Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 53. Europe Opioids Drug Sales Market Share by Country in 2020 Figure 54. Europe Opioids Drug Revenue Market Share by Country in 2020 Figure 55. Europe Opioids Drug Sales Market Share by Type in 2020 Figure 56. Europe Opioids Drug Sales Market Share by Application in 2020 Figure 57. Germany Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 58. France Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 59. UK Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 60. Italy Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 61. Russia Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 62. Middle East & Africa Opioids Drug Sales Market Share by Country in 2020 Figure 63. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2020 Figure 64. Middle East & Africa Opioids Drug Sales Market Share by Type in 2020 Figure 65. Middle East & Africa Opioids Drug Sales Market Share by Application in 2020 Figure 66. Egypt Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 67. South Africa Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 68. Israel Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 69. Turkey Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 70. GCC Country Opioids Drug Revenue Growth 2016-2021 ($ Millions) Figure 71. Channels of Distribution Figure 72. Distributors Profiles